Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
NCT ID: NCT00396097
Last Updated: 2016-04-05
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
316 participants
INTERVENTIONAL
2006-12-31
2012-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age
NCT00174408
Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height
NCT00174421
Growth Retardation In Children With Special Pathological Conditions Or Disease
NCT00163215
Genotropin Treatment in Short Prepubertal Children With Intra-Uterine Growth Retardation
NCT01073605
Effect of Growth Hormone in Children With Growth Hormone Deficiency
NCT00262249
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard
Standard daily HGH treatment
Genotropin
Compare daily injections of formula-based HGH treatment to daily injections of standard HGH treatment in subjects with Idiopathic Short Stature over 24 months period followed by an exploratory 24 months period.
Formula-based
Formula-based dose regimen
Genotropin
Compare daily injections of formula-based HGH treatment to daily injections of standard HGH treatment in subjects with Idiopathic Short Stature over 24 months period followed by an exploratory 24 months period.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Genotropin
Compare daily injections of formula-based HGH treatment to daily injections of standard HGH treatment in subjects with Idiopathic Short Stature over 24 months period followed by an exploratory 24 months period.
Genotropin
Compare daily injections of formula-based HGH treatment to daily injections of standard HGH treatment in subjects with Idiopathic Short Stature over 24 months period followed by an exploratory 24 months period.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Naive to Growth Hormone treatment
Exclusion Criteria
3 Years
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Arkansas Children's Hospital
Little Rock, Alaska, United States
Arkansas Children's Hospital
Little Rock, Arkansas, United States
Children's Hospital of Los Angeles
Los Angeles, California, United States
Rady Children's Hospital - San Diego
San Diego, California, United States
Pediatric Endocrinology of San Diego Medical Group Incorporated
San Diego, California, United States
Childrens Hospital Colorado
Aurora, Colorado, United States
Memorial Pediatric Specialty Clinic
Colorado Springs, Colorado, United States
Pediatric Endocrine Associates
Greenwood Village, Colorado, United States
Pediatric Endocrine Associates at The Longmont Clinic
Longmont, Colorado, United States
Joe DiMaggio Children's Hospital
Hollywood, Florida, United States
Miller School Of Medicine, University of Miami/Jackson Memorial Medical Center
Miami, Florida, United States
Pediatric Endocrinology Associates
Miami, Florida, United States
Arnold Palmer Hospital for Children
Orlando, Florida, United States
Nemours Children's Clinic
Orlando, Florida, United States
Nancy Wright, MD
Tallahassee, Florida, United States
University of Iowa Children's Hospital
Iowa City, Iowa, United States
University of Maryland Baltimore
Baltimore, Maryland, United States
Johns Hopkins Pediatric Endocrinology
Baltimore, Maryland, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Children's Hospital
Boston, Massachusetts, United States
Baystate Medical Center Children's Hospital
Springfield, Massachusetts, United States
Children's Mercy Hospital
Kansas City, Missouri, United States
Children's Endocrine Care of St. Louis, LLC
St Louis, Missouri, United States
Saint Barnabas Ambulatory Care Center
Livingston, New Jersey, United States
Morristown Memorial Hospital
Morristown, New Jersey, United States
Maimonides Medical Center
Brooklyn, New York, United States
Women & Children's Hospital of Buffalo
Buffalo, New York, United States
The Steven and Alexandra Cohen Children's Medical Center of New York (CCMC)
Lake Success, New York, United States
Winthrop University Hospital
Mineola, New York, United States
Mount Sinai School of Medicine
New York, New York, United States
Diabetes & Endocrine Center for Children & Young Adults at Phelps Memorial Hospital
Sleepy Hollow, New York, United States
Children's Hospital at Montefiore
The Bronx, New York, United States
The Research Institute at Nationwide Children's Hospital
Columbus, Ohio, United States
Central Ohio Pediatric Endocrinology/Diabetes Services (COPEDS)
Columbus, Ohio, United States
Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Pediatric Alliance, PC
Pittsburgh, Pennsylvania, United States
Children's Hospital of Pittsburgh of UPMC
Pittsburgh, Pennsylvania, United States
Medical University of South Carolina
Charleston, South Carolina, United States
The Endocrine Clinic P.C.
Memphis, Tennessee, United States
Vanderbilt University
Nashville, Tennessee, United States
Ellen Sher, MD PA
Dallas, Texas, United States
Children's Medical Center
Dallas, Texas, United States
Cooks Children Medical Center/Dept. of Pediatric Endocrinology
Fort Worth, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A6281280
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.